Dr. Barry Dworkin

New stroke-prevention drug may replace warfarin for people with atrial fibrillation

Madely Health Headlines Commentary for November  , 2010

Source:

Approval of new drug heralds ‘momentous’ advance in stroke prevention

Reference:

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial – Lancet Neurology

Related posts:

  1. New blood thinners add value to stroke prevention and quality of life
  2. FDA approval Xarelto for stroke prevention in atrial fibrillation patients questioned
  3. Silent atrial fibrillation a cause for strokes:study
  4. Study unable to show causation for increased stroke risk in first month of warfarin treatment for patients with atrial fibrillation